Incidence of and risk factors for contrast-induced nephropathy after cardiac catheterization in Japanese patients

Circulation Journal

Volumn 73, Issue 8, 2009, Pages 1518-1522

  Abe, Mitsuru ^a   Kimura, Takeshi ^b   Morimoto, Takeshi ^b   Furukawa, Yutaka ^c   Kita, Toru ^c  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

Author keywords

Cardiac catheterization; Contrast induced nephropathy; Risk factors

Indexed keywords

CONTRAST MEDIUM; CREATININE; IOMEPROL; IOPAMIDOL;

ADULT; AGED; ARTICLE; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; DRUG INJECTION VOLUME; DRUG MEGADOSE; FEMALE; HEART CATHETERIZATION; HUMAN; INCIDENCE; JAPANESE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SIDE EFFECT; UNDERWEIGHT; UNIVERSITY HOSPITAL;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CONTRAST MEDIA; FEMALE; HEART CATHETERIZATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; THINNESS;

EID: 69049083708     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-08-0784     Document Type: Article

References (30)

1. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality. Am J Med 1997; 103: 368-375. (Pubitemid 27506242)
2. Freeman RV, O'Donnell M, Share D, Meengs WL, Kline-Rogers E, Clark VL, et al. Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol 2002; 90: 1068-1073. (Pubitemid 35335595)
3. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002; 39: 930-936.
4. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002; 105: 2259-2264.
5. Spargias K, Alexopoulos E, Kyrzopoulos S, Iacovis P, Greenwood DC, Manginas A, et al. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation 2004; 110: 2837-2842. (Pubitemid 39473606)
6. Barrett BJ, Parfrey PS. Clinical practice: Preventing nephropathy induced by contrast medium. N Engl J Med 2006; 354: 379-386.
7. McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol 2008; 51: 1419-1428.
8. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: Development and initial validation. J Am Coll Cardiol 2004; 44: 1393-1399. (Pubitemid 39303939)
9. Maeder M, Klein M, Fehr T, Rickli H. Contrast nephropathy: Review focusing on prevention. J Am Coll Cardiol 2004; 44: 1763-1771. (Pubitemid 39424073)
10. McCullough P. Outcomes of contrast-induced nephropathy: Experience in patients undergoing cardiovascular intervention. Catheter Cardiovasc Interv 2006; 67: 335-343. (Pubitemid 43346729)
11. Pannu N, Wiebe N, Tonelli M. Prophylaxis strategies for contrast-induced nephropathy. JAMA 2006; 295: 2765-2779. (Pubitemid 43920730)
12. Kawashima S, Takano H, Iino Y, Takayama M, Takano T. Prophylactic hemodialysis does not prevent contrast-induced nephropathy after cardiac catheterization in patients with chronic renal insufficiency. Circ J 2006; 70: 553-558.
13. Solomon R, Werner C, Mann D, D'Elia J, Suva P. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994; 331: 1416-1420. (Pubitemid 24348355)
14. Recio-Mayoral A, Chaparro M, Prado B, Cozar R, Mendez I, Banerjee D, et al. The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: The RENO Study. J Am Coll Cardiol 2007; 49: 1283-1288. (Pubitemid 46467227)
15. Briguori C, Airoldi F, D'Andrea D, Bonizzoni E, Morici N, Focaccio A, et al. Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): A randomized comparison of 3 preventive strategies. Circulation 2007; 115: 1211-1217. (Pubitemid 46594764)
16. Solomon RJ, Natarajan MK, Doucet S, Sharma SK, Staniloae CS, Katholi RE, et al. Cardiac Angiography in Renally Impaired Patients (CARE) study: A randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation 2007; 115: 3189-3196. (Pubitemid 47012233)
17. Flegal KM, Graubard BI, Williamson DF, Gail MH. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA 2007; 298: 2028-2037.
18. Nutritional anaemias: Report of a WHO scientific group. World Health Organ Tech Rep Ser 1968; 405: 5-37.
19. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000; 343: 180-184. (Pubitemid 30489215)
20. Artunc FH, Fischer IU, Risler T, Erley CM. Improved estimation of GFR by serum cystatin C in patients undergoing cardiac catheterization. Int Cardiol 2005; 102: 173-178. (Pubitemid 40854029)
21. Shiragami K, Fujii Z, Sakumura T, Shibuya M, Takahashi N, Yano M, et al. Effect of a contrast agent on long-term renal function and the efficacy of prophylactic hemodiafiltration. Circ J 2008; 72: 427-433. (Pubitemid 351600637)
22. Masuda M, Yamada T, Mine T, Morita T, Tamaki S, Tsukamoto Y, et al. Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure. Am J Cardiol 2007; 100: 781-786. (Pubitemid 47268267)
23. Kato K, Sato N, Yamamoto T, Iwasaki YK, Tanaka K, Mizuno K. Valuable markers for contrast-induced nephropathy in patients undergoing cardiac catheterization. Circ J 2008; 72: 1499-1505.
24. Ashby DT, Mehran R, Aymong EA, Lansky AJ, Iakovou I, Weisz G, et al. Comparison of outcomes in men versus women having percutaneous coronary interventions in small coronary arteries. Am J Cardiol 2003; 91: 979-981, A974, A977. (Pubitemid 36398535)
25. Beddhu S. The body mass index paradox and an obesity, inflammation, and atherosclerosis syndrome in chronic kidney disease. Semin Dial 2004; 17: 229-232. (Pubitemid 38824505)
26. Obermayr RP, Temml C, Gutjahr G, Kainz A, Klauser-Braun R, Függer R, et al. Body mass index modifies the risk of cardiovascular death in proteinuric chronic kidney disease. Nephrol Dial Transplant 2009 [E-pub ahead of print].
27. Huber W, Jeschke B, Kreymann B, Hennig M, Page M, Salmhofer H, et al. Haemodialysis for the prevention of contrast-induced nephropathy: Outcome of 31 patients with severely impaired renal function, comparison with patients at similar risk and review. Invest Radiol 2002; 37: 471-481. (Pubitemid 34966852)
28. Mueller C, Buerkle G, Buettner HJ, Petersen J, Perruchoud AP, Eriksson U, et al. Prevention of contrast media-associated nephropathy: Randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002; 162: 329-336. (Pubitemid 34127411)
29. Solomon R. The role of osmolality in the incidence of contrast-induced nephropathy: A systematic review of angiographic contrast media in high risk patients. Kidney Int 2005; 68: 2256-2263. (Pubitemid 43117802)
30. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007; 356: 1503-1516. (Pubitemid 46588415)